Angiotech Partner, Cook Incorporated, Received FDA Permission to Begin First U.S. Tests of a Paclitaxel-Coated Coronary Stent.
Business Wire › March 12, 2001
Linked as:
Extract
Angiotech Partner, Cook Incorporated, Received FDA Permission to Begin First U.S. Tests of a Paclitaxel-Coated Coronary Stent.
Business Editors
VANCOUVER, B.C.--(BUSINESS WIRE)--March 12, 2001 Angiotech Pharmaceuticals, Inc. (NASDAQ:ANPI) (TSE:ANP.) today announced that Cook(R) Incorporated is the first company to receive U.S. Food and Drug Administration (FDA) approval to evaluate a coronary stent coated wit...See the full content of this document
Sponsored links
